(1)
DEMERGER, A PANACEA FOR CORPORATE PROBLEMS - A CASE STUDY ON CROMPTON GREAVES LIMITED. Journal of Pharmaceutical Negative Results 2022, 1507-1511. https://doi.org/10.47750/pnr.2022.13.S06.200.